| Identifiers | ||
| Product Name | Temsirolimus (CCI-779, Torisel) | |
| Catalogue No. | CM726152 | |
| Description | mTOR inhibitor with anti-cancer activity. It has anti-angiogenic effects which may contribute to the antitumor activity of temsirolimus observed in breast cancer. Temsirolimus shows synergistic in vivo anti-myeloma effects in combination with dexamethasone in a xenograft model. | |
| Application | 25 mg. Purity >99%. CAS# 162635-04-3. mTOR inhibitor with anti-cancer activity. It has antiangiogenic effects which may contribute to the antitumor activity of temsirolimus observed in breast cancer.Temsirolimus showed synergistic in vivo antimyeloma effe | |
| CAS Number | 162635-04-3 | |
| Formula | C₅₆H₈₇NO₁₆ | |
| MW | 1030.29 | |
| Storage Condition | -20°C | |
| Brand | Packing | Pricing | Quote request |
| IL | 25 mg | Inquiry | Ask Quote |
Advanced
Technology & Industrial Co., Ltd. all rights reserved |